| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |